Target Price | JPY2,397.00 |
Price | JPY1,486.00 |
Potential |
61.31%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target eGuarantee 2026 .
The average eGuarantee target price is JPY2,397.00.
This is
61.31%
register free of charge
JPY3,150.00
111.98%
register free of charge
JPY1,717.00
15.55%
register free of charge
|
|
A rating was issued by 8 analysts: 6 Analysts recommend eGuarantee to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the eGuarantee stock has an average upside potential 2026 of
61.31%
register free of charge
|
Mar '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion JPY | 10.22 | 11.82 |
11.56% | 15.65% | |
EBITDA Margin | 50.81% | 50.88% |
5.67% | 0.14% | |
Net Margin | 34.14% | 34.69% |
4.09% | 1.60% |
6 Analysts have issued a sales forecast eGuarantee 2026 . The average eGuarantee sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an eGuarantee EBITDA forecast 2026. The average eGuarantee EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 eGuarantee Analysts have issued a net profit forecast 2026. The average eGuarantee net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share JPY | 72.24 | 85.58 |
7.24% | 18.47% | |
P/E | 17.47 | |
EV/Sales | 4.70 |
6 Analysts have issued a eGuarantee forecast for earnings per share. The average eGuarantee EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.